IL164158A0 - Method of administering an injectable antibiotic to an animal - Google Patents

Method of administering an injectable antibiotic to an animal

Info

Publication number
IL164158A0
IL164158A0 IL16415803A IL16415803A IL164158A0 IL 164158 A0 IL164158 A0 IL 164158A0 IL 16415803 A IL16415803 A IL 16415803A IL 16415803 A IL16415803 A IL 16415803A IL 164158 A0 IL164158 A0 IL 164158A0
Authority
IL
Israel
Prior art keywords
animal
administering
antibiotic
injectable antibiotic
injectable
Prior art date
Application number
IL16415803A
Other languages
English (en)
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28454766&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL164158(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of IL164158A0 publication Critical patent/IL164158A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0046Ear
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61DVETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16415803A 2002-03-21 2003-03-19 Method of administering an injectable antibiotic to an animal IL164158A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36621202P 2002-03-21 2002-03-21
PCT/US2003/008571 WO2003079923A1 (en) 2002-03-21 2003-03-19 Method of administering an injectable antibiotic to the ear of an animal

Publications (1)

Publication Number Publication Date
IL164158A0 true IL164158A0 (en) 2005-12-18

Family

ID=28454766

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16415803A IL164158A0 (en) 2002-03-21 2003-03-19 Method of administering an injectable antibiotic to an animal

Country Status (15)

Country Link
US (3) US20030181398A1 (zh)
EP (1) EP1485040B2 (zh)
JP (1) JP4365222B2 (zh)
KR (1) KR20040097187A (zh)
CN (1) CN1635856A (zh)
AT (1) ATE343980T1 (zh)
AU (1) AU2003230697B2 (zh)
BR (1) BR0308523A (zh)
CA (1) CA2476327A1 (zh)
DE (1) DE60309447T3 (zh)
ES (1) ES2275092T5 (zh)
IL (1) IL164158A0 (zh)
MX (1) MXPA04009177A (zh)
WO (1) WO2003079923A1 (zh)
ZA (1) ZA200406501B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107982214B (zh) * 2016-10-26 2021-02-05 华中农业大学 兽用恩诺沙星固体脂质纳米混悬液及其制备方法
EP3558284A2 (en) 2016-12-23 2019-10-30 Intervet International B.V. Compounds for the treatment of bovine or swine respiratory disease
EP3558939A1 (en) 2016-12-23 2019-10-30 Intervet International B.V. Compounds useful for treating a mannheimia haemolytica or histophilus somni infection
CN107802613B (zh) * 2017-11-13 2020-01-31 郑州大学 一种掩味肠道速释型替米考星微纳米干混悬剂及其制备方法
US20210292284A1 (en) * 2018-06-25 2021-09-23 Intervet Inc. Compounds useful for the treatment of infection with mannheimia haemolytica or histophilus somni
WO2020002238A1 (en) 2018-06-25 2020-01-02 Intervet International B.V. Compounds for the treatment of bovine or swine respiratory disease
CN109077999A (zh) * 2018-08-31 2018-12-25 田红卫 一种长效缓释替米考星注射液及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2883984A (en) * 1957-09-09 1959-04-28 Pfizer & Co C Pellet implanter
US2999020A (en) * 1959-06-09 1961-09-05 Hodges Res & Dev Co Processes for the tendering of meat
US4902683A (en) * 1984-10-25 1990-02-20 The Upjohn Company Crystalline cephalosporin hydrohalide salts
EP0386000B1 (en) * 1987-07-29 1992-03-11 The Upjohn Company Controlled release of antibiotic salts from an implant
ZA889601B (en) * 1987-09-23 1989-10-25 Petrus Burger Andries A composition for use in treating animals
US5258528A (en) * 1990-11-30 1993-11-02 Warner-Lambert Company Individual stereoisomers of pyrrolidine methanamines substituted on the ring nitrogen by a 1-phenylethyl group
SK283674B6 (sk) 1993-03-12 2003-11-04 Pharmacia & Upjohn Company Kryštalická voľná kyselina ceftiofuru a spôsob jej prípravy a farmaceutická kompozícia, ktorá ju obsahuje
US6074657A (en) * 1997-03-20 2000-06-13 Pharmacia & Upjohn Company Administration of an injectable antibiotic in the ear of an animal

Also Published As

Publication number Publication date
US20030181398A1 (en) 2003-09-25
CA2476327A1 (en) 2003-10-02
KR20040097187A (ko) 2004-11-17
DE60309447D1 (de) 2006-12-14
DE60309447T2 (de) 2007-03-29
CN1635856A (zh) 2005-07-06
JP2005520624A (ja) 2005-07-14
BR0308523A (pt) 2005-02-01
WO2003079923A1 (en) 2003-10-02
ZA200406501B (en) 2005-06-21
US8968759B2 (en) 2015-03-03
DE60309447T3 (de) 2020-04-23
ATE343980T1 (de) 2006-11-15
EP1485040B1 (en) 2006-11-02
US20150182454A1 (en) 2015-07-02
AU2003230697A1 (en) 2003-10-08
JP4365222B2 (ja) 2009-11-18
ES2275092T5 (es) 2020-06-17
US20110098266A1 (en) 2011-04-28
MXPA04009177A (es) 2004-12-07
AU2003230697B2 (en) 2008-07-17
EP1485040A1 (en) 2004-12-15
EP1485040B2 (en) 2019-12-11
ES2275092T3 (es) 2007-06-01

Similar Documents

Publication Publication Date Title
AU2014235466A8 (en) Dental devices and systems and methods for making the same
IL177944A0 (en) Needle and hub assembly for automatic injector
SE0300924D0 (sv) A method to provide a triple well in an epitaxially based CMOS or BiCMOS process
EP1522719A4 (en) FUEL INJECTION METHOD IN FUEL INJECTION DEVICE
ATE299725T1 (de) Nadelloses subkutaninjektionssystem
ATE442862T2 (de) Niederviskose konzentrierte proteinformulierungen
AU2003237242A1 (en) Needle-free injection system
EP1398566A3 (en) Fluid injector and injection method
AU6880500A (en) Production/injection line and methods relating to same
AU2150497A (en) Improved concentrated injection and infusion solutions for intravenous adminis tration
IL164158A0 (en) Method of administering an injectable antibiotic to an animal
AU4481599A (en) Enema syringe, enema syringe auxiliary and injector and enema method using them
WO2004002421A3 (en) Method for the treatment of multiple sclerosis
MXPA02005511A (es) Control de artropodos en animales.
GB0215488D0 (en) Fuel injection system
WO2004008286A3 (en) Arrangements and methods for treating a subject
AU2003272387A8 (en) System and method for well workover with horizontal tree
RS20050941A (en) Flupirtin injectable galenic form
TR200103841T2 (tr) Tümör büyümesini önlemek için yöntem.
PL371655A1 (en) Fuel injection system
AU2003247367A1 (en) Stimulation and injection system
AU2003234833A1 (en) Injection needle
AU6556700A (en) Method for producing complete units using internal pressure systems based on injection moulding with several components, and assemblies of said units
UA67629A (en) Method for correcting stress component in experimental model of peritonitis
GB0227360D0 (en) Fishplate encapsulation by injection moulding